We serve 4-(4-Fluorophenyl)-3-HydroxyMethyl-1-Methyl-Piperidine CAS:109887-53-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 4-(4-Fluorophenyl)-3-HydroxyMethyl-1-Methyl-Piperidine
CAS.NO: 109887-53-8
Synonyms:
((3R,4S)-rel-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl)methanol
4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl-piperidine
rac-trans Paroxol
Molecular Formula: C13H18FNO
Molecular Weight: 223.28700
Physical and Chemical Properties:
Density: 1.092g / cm3
Boiling point: 300.3ºC at 760mmHg
Melting point: 156-159°C
Flash point: 135.4ºC
Refractive index: 1.518
Specification:
Appearance: White powder
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Paroxetine Mesylate CAS:217797-14-3
Intermediates of Paroxetine hydrochloride CAS:78246-49-8
Intermediates of Paroxetine CAS:61869-08-7
Contact us for information like 4-(4-Fluorophenyl)-3-HydroxyMethyl-1-Methyl-Piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,rac-trans Paroxol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,rac-trans Paroxol Use and application,rac-trans Paroxol technical grade,usp/ep/jp grade.
Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.2-Bromoethanol manufacturer Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.chenodeoxycholic acid supplier U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.2-Bromo-4'-chloroacetophenone vendor U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.
